An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cellsShensi Shen, Caroline Robert|Nature Communications|2019Cited by 99
Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagyShensi Shen, Qiang Yu|The Journal of Cell Biology|2009Cited by 85
Abstract CT087: Early tumor immune microenvironment (TME) modulation by the BRAF inhibitor (BRAFi) dabrafenib (D) and/or the MEK inhibitor (MEKi) trametinib (T) in patients (pts) with <i>BRAF</i> V600E/K-mutant melanoma in the COMBAT trialCaroline Robert, Jean‐Jacques Grob, Delphine Allard et al.|Cancer Research|2018Cited by 1
Mathematical modeling of ribosome competition informs testable treatment strategies for drug-tolerant cancer persister cellsXinpu Tang, Shensi Shen|iScience|2026Cited by 0